Compare $APVO vs $VIVS | Chartloom

Compare

$APVO vs $VIVS

Aptevo Therapeutics Inc · VivoSim Labs Inc

APVO

Aptevo Therapeutics Inc

VIVS

VivoSim Labs Inc

Compare $APVO vs $VIVS

Comparing Aptevo Therapeutics Inc and VivoSim Labs Inc

APVOAptevo Therapeutics Inc

VIVSVivoSim Labs Inc

APVOAptevo Therapeutics Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-80.9%

52W performance

-94.2%

FCF yield

-1132.6%

VIVSVivoSim Labs Inc

Market cap

$2M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.1%

YTD performance

-90.4%

52W performance

-94.3%

FCF yield

-466.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

APVO

VIVS

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

VIVS

VivoSim Labs Inc

Market Cap

APVO$2M

VIVS$2M

Enterprise Value

APVO$-8M

VIVS$502K

Price

APVO$1.79

VIVS$0.18

P/E Ratio

APVON/A

VIVSN/A

P/S Ratio

APVO0.25x

VIVS19.39x

EV/Sales

APVO-0.51x

VIVS4.48x

EV/EBITDA

APVO-0.91x

VIVS0.00x

P/B Ratio

APVO0.53x

VIVS0.73x

P/FCF Ratio

APVON/A

VIVSN/A

EV/FCF

APVO0.30x

VIVS-0.05x

PEG Ratio

APVON/A

VIVSN/A

Forward P/E (NTM)

APVON/A

VIVSN/A

Forward P/S (NTM)

APVON/A

VIVSN/A

Revenue (TTM)

APVO$0

VIVS$112K

Revenue Growth (YoY)

APVON/A

VIVS-21.1%

Forward Rev Growth

APVO206.8%

VIVS0.0%

Gross Margin (TTM)

APVO51.4%

VIVS83.9%

Operating Margin (TTM)

APVO0.0%

VIVS0.0%

EBITDA Margin (TTM)

APVO0.0%

VIVS-9943.8%

Net Margin (TTM)

APVO0.0%

VIVS-11016.1%

FCF Margin (TTM)

APVON/A

VIVS-9038.4%

Net Income (TTM)

APVO$-28M

VIVS$-12M

FCF (TTM)

APVO$-25M

VIVS$-10M

EPS (TTM)

APVO-$23.47

VIVS-$2.35

ROE (TTM)

APVO-20149.0%

VIVS-1556.0%

ROA (TTM)

APVO-11921.0%

VIVS-17702.0%

ROIC (TTM)

APVO-20149.0%

VIVS-1556.0%

Cash

APVO$10M

VIVS$2M

Debt

APVO$0

VIVS$0

Net Cash/Debt

APVO$10M

VIVS$2M

Current Ratio (TTM)

APVO2.08x

VIVS1.70x

Quick Ratio (TTM)

APVO1.98x

VIVS1.43x

Debt/Equity (TTM)

APVO0.00x

VIVS0.00x

Debt/Assets (TTM)

APVO0.0%

VIVS0.0%

Interest Coverage (TTM)

APVON/A

VIVSN/A

Net Debt/EBITDA (TTM)

APVO0.00x

VIVS0.00x

Beta

APVO1.68

VIVS1.57

52W Performance

APVO-94.2%

VIVS-94.3%

YTD Performance

APVO-80.9%

VIVS-90.4%

% from 52W High

APVO-94.6%

VIVS-94.9%

% from 52W Low

APVO30.7%

VIVS7.2%

Asset Turnover (TTM)

APVO0.22x

VIVS0.02x

FCF Yield (TTM)

APVO-1132.6%

VIVS-466.1%

Earnings Yield (TTM)

APVO-1254.8%

VIVS-568.0%

Dividend Yield (TTM)

APVON/A

VIVSN/A

Rule of 40

APVO0.0

VIVS-9,059.5

EV/GP/RG

APVON/A

VIVSN/A

Ticker research

View APVO research View VIVS research

Metric	APVO Aptevo Therapeutics Inc	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$2M	$2M
Enterprise Value	$-8M	$502K
Price	$1.79	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	19.39x
EV/Sales	-0.51x	4.48x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$112K
Revenue Growth (YoY)	N/A	-21.1%
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-9943.8%
Net Margin (TTM)	0.0%	-11016.1%
FCF Margin (TTM)	N/A	-9038.4%
Net Income (TTM)	$-28M	$-12M
FCF (TTM)	$-25M	$-10M
EPS (TTM)	-$23.47	-$2.35
ROE (TTM)	-20149.0%	-1556.0%
ROA (TTM)	-11921.0%	-17702.0%
ROIC (TTM)	-20149.0%	-1556.0%
Financial Health
Cash	$10M	$2M
Debt	$0	$0
Net Cash/Debt	$10M	$2M
Current Ratio (TTM)	2.08x	1.70x
Quick Ratio (TTM)	1.98x	1.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.57
52W Performance	-94.2%	-94.3%
YTD Performance	-80.9%	-90.4%
% from 52W High	-94.6%	-94.9%
% from 52W Low	30.7%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.02x
FCF Yield (TTM)	-1132.6%	-466.1%
Earnings Yield (TTM)	-1254.8%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-9,059.5
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View VIVS research

Valuation

P/S Ratio

APVO

0.25x

VIVS

19.39x

EV/FCF

VIVS

-0.05x

APVO

0.30x

Growth & revenue

Revenue Growth TTM

VIVS

-21.1%

Forward Revenue Growth

APVO

206.8%

VIVS

0.0%

Profitability & performance

Gross Margin

VIVS

83.9%

APVO

51.4%

ROE

VIVS

-1556.0%

APVO

-20149.0%

FCF Yield %

VIVS

-466.1%

APVO

-1132.6%

52-Week Performance

APVO

-94.2%

VIVS

-94.3%

Detailed metrics comparison

APVO

Aptevo Therapeutics Inc

VIVS

VivoSim Labs Inc

Market Cap

APVO$2M

VIVS$2M

Enterprise Value

APVO$-8M

VIVS$502K

Price

APVO$1.79

VIVS$0.18

P/E Ratio

APVON/A

VIVSN/A

P/S Ratio

APVO0.25x

VIVS19.39x

EV/Sales

APVO-0.51x

VIVS4.48x

EV/EBITDA

APVO-0.91x

VIVS0.00x

P/B Ratio

APVO0.53x

VIVS0.73x

P/FCF Ratio

APVON/A

VIVSN/A

EV/FCF

APVO0.30x

VIVS-0.05x

PEG Ratio

APVON/A

VIVSN/A

Forward P/E (NTM)

APVON/A

VIVSN/A

Forward P/S (NTM)

APVON/A

VIVSN/A

Revenue (TTM)

APVO$0

VIVS$112K

Revenue Growth (YoY)

APVON/A

VIVS-21.1%

Forward Rev Growth

APVO206.8%

VIVS0.0%

Gross Margin (TTM)

APVO51.4%

VIVS83.9%

Operating Margin (TTM)

APVO0.0%

VIVS0.0%

EBITDA Margin (TTM)

APVO0.0%

VIVS-9943.8%

Net Margin (TTM)

APVO0.0%

VIVS-11016.1%

FCF Margin (TTM)

APVON/A

VIVS-9038.4%

Net Income (TTM)

APVO$-28M

VIVS$-12M

FCF (TTM)

APVO$-25M

VIVS$-10M

EPS (TTM)

APVO-$23.47

VIVS-$2.35

ROE (TTM)

APVO-20149.0%

VIVS-1556.0%

ROA (TTM)

APVO-11921.0%

VIVS-17702.0%

ROIC (TTM)

APVO-20149.0%

VIVS-1556.0%

Cash

APVO$10M

VIVS$2M

Debt

APVO$0

VIVS$0

Net Cash/Debt

APVO$10M

VIVS$2M

Current Ratio (TTM)

APVO2.08x

VIVS1.70x

Quick Ratio (TTM)

APVO1.98x

VIVS1.43x

Debt/Equity (TTM)

APVO0.00x

VIVS0.00x

Debt/Assets (TTM)

APVO0.0%

VIVS0.0%

Interest Coverage (TTM)

APVON/A

VIVSN/A

Net Debt/EBITDA (TTM)

APVO0.00x

VIVS0.00x

Beta

APVO1.68

VIVS1.57

52W Performance

APVO-94.2%

VIVS-94.3%

YTD Performance

APVO-80.9%

VIVS-90.4%

% from 52W High

APVO-94.6%

VIVS-94.9%

% from 52W Low

APVO30.7%

VIVS7.2%

Asset Turnover (TTM)

APVO0.22x

VIVS0.02x

FCF Yield (TTM)

APVO-1132.6%

VIVS-466.1%

Earnings Yield (TTM)

APVO-1254.8%

VIVS-568.0%

Dividend Yield (TTM)

APVON/A

VIVSN/A

Rule of 40

APVO0.0

VIVS-9,059.5

EV/GP/RG

APVON/A

VIVSN/A

Ticker research

View APVO research View VIVS research

Metric	APVO Aptevo Therapeutics Inc	VIVS VivoSim Labs Inc
Market & Valuation
Market Cap	$2M	$2M
Enterprise Value	$-8M	$502K
Price	$1.79	$0.18
P/E Ratio	N/A	N/A
P/S Ratio	0.25x	19.39x
EV/Sales	-0.51x	4.48x
EV/EBITDA	-0.91x	0.00x
P/B Ratio	0.53x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	0.30x	-0.05x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$112K
Revenue Growth (YoY)	N/A	-21.1%
Forward Rev Growth	206.8%	0.0%
Profitability
Gross Margin (TTM)	51.4%	83.9%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-9943.8%
Net Margin (TTM)	0.0%	-11016.1%
FCF Margin (TTM)	N/A	-9038.4%
Net Income (TTM)	$-28M	$-12M
FCF (TTM)	$-25M	$-10M
EPS (TTM)	-$23.47	-$2.35
ROE (TTM)	-20149.0%	-1556.0%
ROA (TTM)	-11921.0%	-17702.0%
ROIC (TTM)	-20149.0%	-1556.0%
Financial Health
Cash	$10M	$2M
Debt	$0	$0
Net Cash/Debt	$10M	$2M
Current Ratio (TTM)	2.08x	1.70x
Quick Ratio (TTM)	1.98x	1.43x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	1.57
52W Performance	-94.2%	-94.3%
YTD Performance	-80.9%	-90.4%
% from 52W High	-94.6%	-94.9%
% from 52W Low	30.7%	7.2%
Efficiency & Yields
Asset Turnover (TTM)	0.22x	0.02x
FCF Yield (TTM)	-1132.6%	-466.1%
Earnings Yield (TTM)	-1254.8%	-568.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-9,059.5
EV/GP/RG	N/A	N/A
Ticker research	View APVO research	View VIVS research